Kaewput Chalermrat, Suppiah Subapriya, Vinjamuri Sobhan
Department of Radiology, Division of Nuclear Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Selangor, Malaysia.
World J Nucl Med. 2018 Jan-Mar;17(1):34-40. doi: 10.4103/wjnm.WJNM_16_17.
The aim of our study was to correlate tumor uptake of Ga-DOTA-NOC positron emission tomography/computed tomography (PET/CT) with the pathological grade of neuroendocrine tumors (NETs). Ga-DOTA-NOC PET/CT examinations in 41 patients with histopathologically proven NETs were included in the study. Maximum standardized uptake value (SUV) and averaged SUV SUV of "main tumor lesions" were calculated for quantitative analyses after background subtraction. Uptake on main tumor lesions was compared and correlated with the tumor histological grade based on Ki-67 index and pathological differentiation. Classification was performed into three grades according to Ki-67 levels; low grade: Ki-67 <2, intermediate grade: Ki-67 3-20, and high grade: Ki-67 >20. Pathological differentiation was graded into well- and poorly differentiated groups. The values were compared and evaluated for correlation and agreement between the two parameters was performed. Our study revealed negatively fair agreement between SUV of tumor and Ki-67 index ( = -0.241) and negatively poor agreement between SUV of tumor and Ki-67 index ( = -0.094). SUV of low-grade, intermediate-grade, and high-grade Ki-67 index is 26.18 ± 14.56, 30.71 ± 24.44, and 6.60 ± 4.59, respectively. Meanwhile, SUV of low-grade, intermediate-grade, and high-grade Ki-67 is 8.92 ± 7.15, 9.09 ± 5.18, and 3.00 ± 1.38, respectively. As expected, there was statistically significant decreased SUV and SUV in high-grade tumors (poorly differentiated NETs) as compared with low- and intermediate-grade tumors (well-differentiated NETs). SUV of Ga-DOTA-NOC PET/CT is not correlated with histological grade of NETs. However, there was statistically significant decreased tumor uptake of Ga-DOTA-NOC in poorly differentiated NETs as compared with the well-differentiated group. As a result of this pilot study, we confirm that the lower tumor uptake of Ga-DOTA-NOC may be associated with aggressive behavior and may, therefore, result in poor prognosis.
我们研究的目的是将镓-多胺大环配体-奥曲肽正电子发射断层扫描/计算机断层扫描(PET/CT)的肿瘤摄取与神经内分泌肿瘤(NETs)的病理分级相关联。本研究纳入了41例经组织病理学证实为NETs的患者的镓-多胺大环配体-奥曲肽PET/CT检查。在扣除背景后,计算“主要肿瘤病灶”的最大标准化摄取值(SUV)和平均SUV进行定量分析。将主要肿瘤病灶的摄取情况与基于Ki-67指数和病理分化的肿瘤组织学分级进行比较并关联。根据Ki-67水平分为三个等级;低级别:Ki-67<2,中级别:Ki-67 3-20,高级别:Ki-67>20。病理分化分为高分化和低分化组。对这些值进行比较并评估相关性,同时对两个参数之间的一致性进行分析。我们的研究显示肿瘤SUV与Ki-67指数之间的一致性为负相关(=-0.241),肿瘤SUV与Ki-67指数之间的一致性为负相关(=-0.094)。低级别、中级别和高级别Ki-67指数的SUV分别为26.18±14.56、30.71±24.44和6.60±4.59。同时,低级别、中级别和高级别Ki-67的SUV分别为8.92±7.15、9.09±5.18和3.00±1.38。正如预期的那样,与低级别和中级别肿瘤(高分化NETs)相比,高级别肿瘤(低分化NETs)的SUV和SUV在统计学上显著降低。镓-多胺大环配体-奥曲肽PET/CT的SUV与NETs的组织学分级无关。然而,与高分化组相比,低分化NETs中镓-多胺大环配体-奥曲肽的肿瘤摄取在统计学上显著降低。作为这项初步研究的结果,我们证实镓-多胺大环配体-奥曲肽较低的肿瘤摄取可能与侵袭性行为相关,因此可能导致预后不良。